KRH-3955
Modify Date: 2024-01-06 17:58:34
KRH-3955 structure
|
Common Name | KRH-3955 | ||
|---|---|---|---|---|
| CAS Number | 1097732-62-1 | Molecular Weight | 929.964 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C40H63N7O18 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KRH-3955A potent, selective, orally bioavailable inhibitor of CXCR4 that efficiently inhibits SDF-1α binding to CXCR4 with IC50 of 0.61 nM. |
| Name | KRH-3955 |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C40H63N7O18 |
|---|---|
| Molecular Weight | 929.964 |
| Exact Mass | 929.422974 |
| Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with N1-[4-(dipropylamino)butyl]-N4-(1H-imidazol-2-ylmethyl)-N1-methyl-N4-[(1-methyl-1H-imidazol-2-yl)methyl]-1,4-benzenedimethanamine (3:1) |
| KRH-3955 |
| (2R,3R)-2,3-Dihydroxysuccinic acid - N-[4-({(1H-imidazol-2-ylmethyl)[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)benzyl]-N-methyl-N',N'-dipropyl-1,4-butanediamine (3:1) |
| SF655E80Z8 |